Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Loss of p53 promotes RhoA-ROCK-dependent cell migration and invasion in 3D matrices.

Gadea G, de Toledo M, Anguille C, Roux P.

J Cell Biol. 2007 Jul 2;178(1):23-30.

2.

Lack of extracellular signal-regulated kinase mitogen-activated protein kinase signaling shows a new type of melanoma.

Shields JM, Thomas NE, Cregger M, Berger AJ, Leslie M, Torrice C, Hao H, Penland S, Arbiser J, Scott G, Zhou T, Bar-Eli M, Bear JE, Der CJ, Kaufmann WK, Rimm DL, Sharpless NE.

Cancer Res. 2007 Feb 15;67(4):1502-12.

3.

RhoE is a pro-survival p53 target gene that inhibits ROCK I-mediated apoptosis in response to genotoxic stress.

Ongusaha PP, Kim HG, Boswell SA, Ridley AJ, Der CJ, Dotto GP, Kim YB, Aaronson SA, Lee SW.

Curr Biol. 2006 Dec 19;16(24):2466-72. Erratum in: Curr Biol. 2012 Nov 20;22(22):2186-7.

4.

Fibronectin matrix assembly requires distinct contributions from Rho kinases I and -II.

Yoneda A, Ushakov D, Multhaupt HA, Couchman JR.

Mol Biol Cell. 2007 Jan;18(1):66-75. Epub 2006 Oct 25.

5.

Mutant B-RAF signaling and cyclin D1 regulate Cks1/S-phase kinase-associated protein 2-mediated degradation of p27Kip1 in human melanoma cells.

Bhatt KV, Hu R, Spofford LS, Aplin AE.

Oncogene. 2007 Feb 15;26(7):1056-66. Epub 2006 Aug 21.

PMID:
16924241
6.
7.

The activity status of cofilin is directly related to invasion, intravasation, and metastasis of mammary tumors.

Wang W, Mouneimne G, Sidani M, Wyckoff J, Chen X, Makris A, Goswami S, Bresnick AR, Condeelis JS.

J Cell Biol. 2006 May 8;173(3):395-404. Epub 2006 May 1.

8.

B-RAF and PI-3 kinase signaling protect melanoma cells from anoikis.

Boisvert-Adamo K, Aplin AE.

Oncogene. 2006 Aug 10;25(35):4848-56. Epub 2006 Mar 20.

PMID:
16547495
9.

Function and regulation of Rnd proteins.

Chardin P.

Nat Rev Mol Cell Biol. 2006 Jan;7(1):54-62. Review.

PMID:
16493413
10.

Alphavbeta3 integrin and cofilin modulate K1735 melanoma cell invasion.

Dang D, Bamburg JR, Ramos DM.

Exp Cell Res. 2006 Feb 15;312(4):468-77. Epub 2005 Dec 6.

PMID:
16337627
11.

Rho GTPases: biochemistry and biology.

Jaffe AB, Hall A.

Annu Rev Cell Dev Biol. 2005;21:247-69. Review.

PMID:
16212495
12.

RhoC is dispensable for embryogenesis and tumor initiation but essential for metastasis.

Hakem A, Sanchez-Sweatman O, You-Ten A, Duncan G, Wakeham A, Khokha R, Mak TW.

Genes Dev. 2005 Sep 1;19(17):1974-9. Epub 2005 Aug 17.

13.

Mutant V599EB-Raf regulates growth and vascular development of malignant melanoma tumors.

Sharma A, Trivedi NR, Zimmerman MA, Tuveson DA, Smith CD, Robertson GP.

Cancer Res. 2005 Mar 15;65(6):2412-21.

14.

RhoE function is regulated by ROCK I-mediated phosphorylation.

Riento K, Totty N, Villalonga P, Garg R, Guasch R, Ridley AJ.

EMBO J. 2005 Mar 23;24(6):1170-80. Epub 2005 Mar 3.

15.

Small G-protein RhoE is underexpressed in prostate cancer and induces cell cycle arrest and apoptosis.

Bektic J, Pfeil K, Berger AP, Ramoner R, Pelzer A, Schäfer G, Kofler K, Bartsch G, Klocker H.

Prostate. 2005 Sep 1;64(4):332-40.

PMID:
15754346
16.

Adhesion control of cyclin D1 and p27Kip1 levels is deregulated in melanoma cells through BRAF-MEK-ERK signaling.

Bhatt KV, Spofford LS, Aram G, McMullen M, Pumiglia K, Aplin AE.

Oncogene. 2005 May 12;24(21):3459-71.

PMID:
15735667
17.

Oncogenic K-RAS is required to maintain changes in cytoskeletal organization, adhesion, and motility in colon cancer cells.

Pollock CB, Shirasawa S, Sasazuki T, Kolch W, Dhillon AS.

Cancer Res. 2005 Feb 15;65(4):1244-50.

18.

Molecular mechanisms of invadopodium formation: the role of the N-WASP-Arp2/3 complex pathway and cofilin.

Yamaguchi H, Lorenz M, Kempiak S, Sarmiento C, Coniglio S, Symons M, Segall J, Eddy R, Miki H, Takenawa T, Condeelis J.

J Cell Biol. 2005 Jan 31;168(3):441-52.

19.
20.

RhoE inhibits cell cycle progression and Ras-induced transformation.

Villalonga P, Guasch RM, Riento K, Ridley AJ.

Mol Cell Biol. 2004 Sep;24(18):7829-40.

Supplemental Content

Support Center